MG
TMO icon

Michael Gelband’s Thermo Fisher Scientific TMO Stock Holding History

Michael Gelband’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.4M Buy
+32,661
New +$15.7M 0.11% 172
2025
Q3 		– Sell
-19,985
Closed -$8.1M – 2021
2025
Q2 		$8.1M Buy
+19,985
New +$8.36M 0.07% 290
2024
Q2 		– Sell
-15,409
Closed -$8.96M – 1984
2024
Q1 		$8.96M Sell
15,409
-22,547
-59% -$12.7M 0.07% 223
2023
Q4 		$20.1M Sell
37,956
-7,995
-17% -$3.87M 0.13% 100
2023
Q3 		$23.3M Buy
45,951
+18,350
+66% +$9.78M 0.22% 82
2023
Q2 		$14.4M Buy
27,601
+13,337
+94% +$7.2M 0.12% 171
2023
Q1 		$8.22M Buy
+14,264
New +$8.04M 0.07% 343
2022
Q3 		– Sell
-13,548
Closed -$7.36M – 2310
2022
Q2 		$7.36M Buy
13,548
+972
+8% +$535K 0.09% 277
2022
Q1 		$7.43M Sell
12,576
-15,031
-54% -$8.63M 0.09% 267
2021
Q4 		$18.4M Buy
27,607
+17,491
+173% +$10.9M 0.19% 89
2021
Q3 		$5.78M Sell
10,116
-14,866
-60% -$8.16M 0.08% 344
2021
Q2 		$12.6M Sell
24,982
-7,625
-23% -$3.6M 0.14% 102
2021
Q1 		$14.9M Buy
32,607
+8,947
+38% +$4.27M 0.22% 78
2020
Q4 		$11M Buy
23,660
+17,111
+261% +$8.02M 0.11% 107
2020
Q3 		$2.89M Sell
6,549
-14,168
-68% -$5.85M 0.06% 287
2020
Q2 		$7.51M Buy
20,717
+12,301
+146% +$4.12M 0.19% 94
2020
Q1 		$2.39M Buy
8,416
+889
+12% +$280K 0.13% 158
2019
Q4 		$2.44M Buy
7,527
+5,914
+367% +$1.79M 0.05% 295
2019
Q3 		$470K Sell
1,613
-31,329
-95% -$8.97M 0.02% 686
2019
Q2 		$9.67M Buy
32,942
+20,753
+170% +$5.72M 0.38% 34
2019
Q1 		$3.34M Buy
12,189
+11,267
+1,222% +$2.8M 0.25% 69
2018
Q4 		$206K Buy
+922
New +$216K 0.01% 265

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Michael Gelband's TMO Position: Q2 2026 in Review

Michael Gelband opened a new position in Thermo Fisher Scientific (TMO) in Q2 2026: 32,661 shares worth $16.4M. The stake represents 0.11% of the portfolio and ranks #172 among its holdings. This is a return to the name: Michael Gelband previously reported a position in TMO as recently as Q2 2025.

Michael Gelband first reported a position in TMO in Q4 2018 and has held it in 22 quarters since. The position peaked at $23.3M in Q3 2023. 2,606 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Michael Gelband held 32,661 shares of Thermo Fisher Scientific worth $16.4M as of Q2 2026.
  • Thermo Fisher Scientific was a new Michael Gelband position in Q2 2026.
  • Thermo Fisher Scientific made up 0.11% of Michael Gelband's portfolio in Q2 2026, its #172 holding.
  • Michael Gelband first reported a position in Thermo Fisher Scientific in Q4 2018 and has held it in 22 quarters since.
  • Michael Gelband's Thermo Fisher Scientific position peaked at $23.3M in Q3 2023.
  • 2,606 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.